tamibarotene,sy-5609
syros
['pancreatic', 'select,mds,1', 'sy-5609 ', 'aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)', 'mds', 'syrospharma', '$syrs']
across the recent #asco22 &amp; upcoming #eha2022 conferences, $syrs shares trial in progress abstracts, detailing the designs of our sy-5609 trial in pancreatic cancer, our select-mds-1 trial &amp; our select-aml-1 trial. learn more about our #oncology programs: 
By redefining the power of small molecules to control the expression of genes, we aim to develop medicines that provide a profound benefit for patients.